Device Trial Radar · NCT02145351
Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure
Last checked: Nov 20, 2026Latest source record: Apr 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Apr 7, 2014
Primary completion
May 9, 2022
Study completion May 9, 2022
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic
- First posted
- May 22, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Determine the impact of restoring normal heart rate response during exercise and daily activity in patients with heart failure and a preserved ejection fraction (HFpEF) and chronotropic incompetence (CI).
Conditions
- Heart Failure With a Preserved Ejection Fraction
- Heart Failure, Diastolic
- Chronotropic Incompetence
Interventions
Rate adaptive atrial pacing using a dual-chamber pacemakerDevice
The Azure XT DR is a permanent, dual-chamber cardiac pacemaker with the ability to continuously monitor and record patient activity, and respond to activity by pacing faster and increasing the heart rate (rate adaptive atrial pacing). It will be programmed in AAIR mode to pace the right atrium. The leads will be placed in the right atrium and right ventricle using CapSureFix model 5086.
Pacemaker system will be implanted but set to Pacing Off.Device
The identical pacing system will be implanted, but will be set to Pacing Off.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Oxygen Consumption (VO2) at Ventilatory Anaerobic Threshold (VAT)Time frame: baseline, after 4 weeks of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic in Rochester
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.